ICM
DNB

Invenomic Capital Management’s Dun & Bradstreet DNB Stock Holding History

Invenomic Capital Management’s Portfolio DNB Stock Details DNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,757,619
Closed -$33.6M – 162
2025
Q1 		$33.6M Buy
3,757,619
+1,944,897
+107% +$19.9M 1.7% 13
2024
Q4 		$22.6M Sell
1,812,722
-378,078
-17% -$4.52M 1.07% 23
2024
Q3 		$25.2M Buy
2,190,800
+142,614
+7% +$1.58M 1.39% 19
2024
Q2 		$19M Buy
+2,048,186
New +$19.7M 0.92% 34

Other funds holding DNB

CH
Cannae Holdings Las Vegas, Nevada $134M AUM 85.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
THLTP
Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Invenomic Capital Management's DNB Position: Q2 2025 in Review

Invenomic Capital Management sold out of Dun & Bradstreet (DNB) in Q2 2025, closing a stake of 3,757,619 shares — an estimated $33.6M sold.

Invenomic Capital Management first reported a position in DNB in Q2 2024 and held it in 4 quarters. The position peaked at $33.6M in Q1 2025. 274 funds tracked by Wall St. Rank hold DNB as of Q2 2025.

  • Invenomic Capital Management reported no remaining Dun & Bradstreet position as of Q2 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 3,757,619 Dun & Bradstreet shares in Q2 2025, an estimated $33.6M.
  • Invenomic Capital Management first reported a position in Dun & Bradstreet in Q2 2024 and held it in 4 quarters.
  • Invenomic Capital Management's Dun & Bradstreet position peaked at $33.6M in Q1 2025.
  • 274 funds tracked by Wall St. Rank held Dun & Bradstreet as of Q2 2025.

Based on Invenomic Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.